Charles Schwab Investment Management »

Perspective Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.8M 434k 13.35
2024-06-30 $1.3M 135k 9.97

More positions owned by Charles Schwab Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Broadcom (AVGO)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Schwab Strategic Tr Fundamental Intl (FNDF)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Charles Schwab Investment Management

Top funds holding Perspective Therapeutics

Henderson Group
BlackRock
BlackRock
Avidity Partners Management
Commodore Capital
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Marshall Wace
Octagon Capital Advisors
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors

View all funds holding Perspective Therapeutics